Drug Shortage Report for HAVRIX 720 JUNIOR

Last updated on 2018-02-22 History
Report ID 18721
Drug Identification Number 02231056
Brand name HAVRIX 720 JUNIOR
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 720UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's (prefilled syringe)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-08-08
Estimated end date 2018-02-28
Actual end date 2018-02-21
Shortage status Resolved
Updated date 2018-02-22
Company comments Most recent supply released February 7, 2018 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-08-10 English Compare
v2 2017-08-10 French Compare
v3 2017-08-16 English Compare
v4 2017-08-16 French Compare
v5 2017-09-08 English Compare
v6 2017-09-08 French Compare
v7 2017-11-22 English Compare
v8 2017-11-22 French Compare
v9 2018-01-25 English Compare
v10 2018-01-25 French Compare
v11 2018-02-08 English Compare
v12 2018-02-08 French Compare
v13 2018-02-22 English Compare
v14 2018-02-22 French Compare

Showing 1 to 14 of 14